A 5-year prospective follow-up study in essential cryofibrinogenemia patients by C. Belizna et al.
A 5-year prospective follow-up study in essential
cryofibrinogenemia patients
Submitted by Emmanuel Lemoine on Tue, 02/24/2015 - 15:21
Titre A 5-year prospective follow-up study in essential cryofibrinogenemia patients
Type de
publication Article de revue
Auteur
Belizna, C. [1], Loufrani, Laurent [2], Subra, Jean-François [3], Godin, M. [4], Jolly,
P. [5], Vitecocq, O. [6], Faller, B. [7], Ghali, A. [8], Tron, F. [9], Hamidou, M. [10],
Henrion, Daniel [11], Levesque, H. [12], Ifrah, Norbert [13]
Editeur Elsevier











Adult [14], Aged [15], Cryoglobulinemia/diagnosis/epidemiology/etiology [16],
Female [17], Follow-Up Studies [18], Humans [19], Lymphoma/complications [20],




INTRODUCTION: Cryofibrinogenemia may be essential, or secondary to diseases
such as neoplasia, infection, thrombosis, and collagen vascular diseases. In a
previous study, we reported the occurrence of neoplasia in some essential
cryofibrinogenemia patients after a short period of follow-up. PURPOSE: We
performed a prospective multi-center 5-year follow-up study in essential
cryofibrinogenemia patients (2005-2009). RESULTS: 23 patients with essential
cryofibrinogenemia were included, mean age 59 years (range: 33-79), 14 males.
After a mean follow-up period of 24 months, 11/23 (47%) of cases that were initially
diagnosed as essential cryofibrinogenemia were found to have an underlying
lymphoma (6 T lymphoma and 5 B lymphoma). CONCLUSION: This prospective
study suggests that some cases of cryofibrinogenemia that are initially considered
as essential, may have underlying lymphoma. Thus, we further suggest that regular
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